Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biodesix, Inc. stock logo
BDSX
Biodesix
$0.28
+0.4%
$0.34
$0.17
$2.04
$40.45M0.972.45 million shs505,376 shs
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
$0.33
-14.8%
$0.32
$0.25
$1.20
$17.03M1.19169,662 shs4.12 million shs
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
$3.39
-3.8%
$3.67
$2.92
$6.30
$125.79M-0.0483,273 shs55,397 shs
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
$1.78
$1.92
$1.35
$4.07
$77.32M0.56398,764 shs110,105 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biodesix, Inc. stock logo
BDSX
Biodesix
-4.18%+1.89%-11.23%-53.76%-82.59%
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
0.00%0.00%0.00%+2.20%-69.63%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
+2.92%-3.83%-3.83%-5.38%-5.63%
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
+1.71%-7.77%+2.89%-19.09%-42.95%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Biodesix, Inc. stock logo
BDSX
Biodesix
3.402 of 5 stars
4.44.00.00.00.02.50.6
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
N/AN/AN/AN/AN/AN/AN/AN/A
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
0.7706 of 5 stars
0.05.00.00.01.50.00.6
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
2.3772 of 5 stars
3.54.00.00.00.01.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Biodesix, Inc. stock logo
BDSX
Biodesix
2.80
Moderate Buy$1.75534.06% Upside
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
0.00
N/AN/AN/A
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
4.00
Strong BuyN/AN/A
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
3.00
Buy$2.8560.11% Upside

Current Analyst Ratings Breakdown

Latest ENZ, BDSX, EUDA, and QIPT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/21/2025
Biodesix, Inc. stock logo
BDSX
Biodesix
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Outperform ➝ Sector Outperform$3.00 ➝ $2.00
5/14/2025
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$6.00 ➝ $4.00
5/14/2025
Biodesix, Inc. stock logo
BDSX
Biodesix
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$3.00 ➝ $2.00
5/14/2025
Biodesix, Inc. stock logo
BDSX
Biodesix
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$3.00 ➝ $1.50
5/14/2025
Biodesix, Inc. stock logo
BDSX
Biodesix
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$2.50 ➝ $1.50
5/14/2025
Biodesix, Inc. stock logo
BDSX
Biodesix
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Market Perform
5/13/2025
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$4.00 ➝ $1.70
4/29/2025
Biodesix, Inc. stock logo
BDSX
Biodesix
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$3.50 ➝ $2.50
(Data available from 7/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Biodesix, Inc. stock logo
BDSX
Biodesix
$74.46M0.54N/AN/A$0.14 per share1.97
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
$29.09M0.59N/AN/A$1.09 per share0.30
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
$4.01M31.37N/AN/A($0.07) per share-48.36
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
$245.91M0.31$1.03 per share1.72$2.49 per share0.71
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Biodesix, Inc. stock logo
BDSX
Biodesix
-$42.93M-$0.29N/AN/AN/A-54.28%-167.28%-39.96%8/6/2025 (Estimated)
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
-$26.08MN/A0.00N/A-75.34%-7.96%-5.49%N/A
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
-$15.36MN/A0.00N/AN/AN/AN/AN/A7/29/2025 (Estimated)
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
-$6.76M-$0.21N/AN/AN/A-3.66%-8.38%-3.63%8/13/2025 (Estimated)

Latest ENZ, BDSX, EUDA, and QIPT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/29/2025N/A
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
-$0.02N/AN/AN/AN/AN/A
5/13/2025Q1 2025
Biodesix, Inc. stock logo
BDSX
Biodesix
-$0.08-$0.08N/A-$0.08$19.50 million$17.96 million
5/12/2025Q2 2025
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
$0.02-$0.07-$0.09-$0.07$88.29 million$57.40 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Biodesix, Inc. stock logo
BDSX
Biodesix
N/AN/AN/AN/AN/A
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
$0.40123.08%N/AN/AN/A
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/AN/AN/AN/AN/A
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Biodesix, Inc. stock logo
BDSX
Biodesix
3.32
2.22
2.22
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
N/A
2.55
2.28
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/A
0.18
0.15
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
0.76
1.22
0.85

Institutional Ownership

CompanyInstitutional Ownership
Biodesix, Inc. stock logo
BDSX
Biodesix
20.96%
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
36.90%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
4.35%
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
42.85%

Insider Ownership

CompanyInsider Ownership
Biodesix, Inc. stock logo
BDSX
Biodesix
30.10%
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
11.40%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/A
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
13.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Biodesix, Inc. stock logo
BDSX
Biodesix
220146.56 million102.45 millionOptionable
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
52052.40 million46.29 millionOptionable
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
237.16 millionN/ANot Optionable
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
1,20043.44 million37.62 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Biodesix stock logo

Biodesix NASDAQ:BDSX

$0.28 +0.00 (+0.36%)
Closing price 03:56 PM Eastern
Extended Trading
$0.28 +0.00 (+0.72%)
As of 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

Enzo Biochem stock logo

Enzo Biochem NYSE:ENZ

$0.32 -0.06 (-14.83%)
Closing price 04/17/2025
Extended Trading
$0.32 0.00 (0.00%)
As of 04/17/2025 05:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Enzo Biochem, Inc. develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. It also provides AMPIVIEW in situ hybridization probes for enhanced detection of low expressed targets useful in the growing spatial biology space; reagents and assays for cell and gene therapy research and development; POLYVIEW PLUS Enhanced Immunohistochemistry platform, offers solutions within the area of anatomical pathology through optimized assays; Enhanced Immunoassays, pushing sensitivity to expand immunoassay applications for basic research, bioprocess, and diagnostics; AMPIPROBE, a nucleic acid amplification platform; and Axxora.com, a proven distribution platform for original manufacturers of innovative research reagents. The company's proprietary products and technologies in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. It markets its products and services through its direct sales force and a network of distributors. The company was incorporated in 1976 and is headquartered in Farmingdale, New York.

EUDA Health stock logo

EUDA Health NASDAQ:EUDA

$3.38 -0.14 (-3.84%)
As of 01:04 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company is also involved in the property management that services shopping malls, business office building, or residential apartments. EUDA Health Holdings Limited is headquartered in Singapore.

Quipt Home Medical stock logo

Quipt Home Medical NASDAQ:QIPT

$1.78 0.00 (0.00%)
As of 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.